NYSE:AGN - Allergan Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $160.22 +3.66 (+2.34 %) (As of 01/18/2019 04:00 PM ET)Previous Close$160.22Today's Range$156.32 - $160.6652-Week Range$125.84 - $197.00Volume2.89 million shsAverage Volume2.48 million shsMarket Capitalization$52.81 billionP/E Ratio9.80Dividend Yield1.84%Beta1.32 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Allergan (NYSE:AGN) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.21 Wall Street analysts have issued ratings and price targets for Allergan in the last 12 months. Their average twelve-month price target is $211.2778, suggesting that the stock has a possible upside of 31.87%. The high price target for AGN is $265.00 and the low price target for AGN is $164.00. There are currently 4 hold ratings and 17 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.812.822.822.71Ratings Breakdown: 0 Sell Rating(s)4 Hold Rating(s)17 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)18 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)18 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)15 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $211.2778$213.4737$214.8535$212.1616Price Target Upside: 31.87% upside59.13% upside13.39% upside22.36% upsideAllergan (NYSE:AGN) Consensus Price Target History Allergan (NYSE:AGN) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails1/8/2019Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$200.00 ➝ $197.00Low1/4/2019Cantor FitzgeraldSet Price TargetHold$180.00Low12/20/2018Morgan StanleySet Price TargetBuy$183.00Medium11/30/2018Royal Bank of CanadaSet Price TargetBuy$220.00Medium11/12/2018Leerink SwannInitiated CoverageOutperform$220.00Low10/31/2018Wells Fargo & CoReiterated RatingBuyHigh10/31/2018Raymond JamesLower Price TargetOutperform ➝ Buy$232.00 ➝ $198.00Low10/30/2018CowenSet Price TargetBuy$255.00Medium10/8/2018GuggenheimInitiated CoverageBuy ➝ BuyMedium9/18/2018SunTrust BanksBoost Price TargetBuy$218.00Medium9/17/2018Piper Jaffray CompaniesSet Price TargetHold$164.00Low9/12/2018Deutsche BankSet Price TargetBuy$210.00Medium8/3/2018MizuhoUpgradeNeutral ➝ BuyLow7/5/2018ArgusReiterated RatingHoldMedium6/12/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$209.00 ➝ $213.00Low6/8/2018Sanford C. BernsteinSet Price TargetBuy$232.00High4/24/2018CitigroupReiterated RatingBuy ➝ Buy$220.00 ➝ $200.00Medium4/23/2018Evercore ISIInitiated CoverageOutperformLow4/17/2018Stifel NicolausInitiated CoverageHold ➝ Hold$192.00Low3/15/2018JPMorgan Chase & Co.Set Price TargetBuy$265.00Low1/29/2018BarclaysUpgradeEqual Weight ➝ Overweight$220.00 ➝ $230.00Low1/10/2018UBS GroupSet Price TargetBuy$250.00Medium10/18/2017Edward JonesReiterated RatingBuy ➝ HoldN/A5/10/2017Goldman Sachs GroupDowngradeBuy ➝ Neutral$262.00High(Data available from 1/19/2017 forward) This page was last updated on 1/19/2019 by MarketBeat.com StaffFeatured Article: What is a Backdoor Roth IRA?